arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Evolent Health, Inc.

EVH
$3.97 ▲ +0.38 (+10.58%) at close
Industrials ·Services-Management Services ·USServices-Management Services
51 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Evolent Health, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $444.3M
Dividend Yield
Revenue Growth 2.6%
Op. Margin -2.1%
ROIC -0.8%
FCF / Share $-0.01
Trailing P/E
Price / Book 1.1x
FCF Yield
Debt / Equity 2.46
info Valuation on last close. End-of-day price, Aug 7, 2026.

51-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$496.25M
↑ +2.6%
Net Income Profit after all expenses
$-26.63M
↑ +58.8%
Operating Margin Operating profit as % of sales
-2.1%
↑ +97.5% 9th
FCF / Share Free cash flow per share
$-0.01
↓ -106.3%
Long-Term Debt Long-term obligations
$973.49M
— +0.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
17
Returns
6
Financial Health
11
Cash Quality
19

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 51 quarters